Pulmonx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	83.78	101.97	148.71	231.79	14.77	4.12
Short-Term Investments	33.56	39.4	31.56	0	13.58	0
Cash & Cash Equivalents	117.34	141.37	180.27	231.79	28.35	4.12
Cash Growth	-17.00%	-21.58%	-22.23%	717.69%	587.37%	-
Receivables	12.11	8.68	6.56	4.23	5.51	2.95
Inventory	19.32	19.85	16.29	10.74	5.61	3.32
Other Current Assets	1.66	-0.94	4.88	3.23	1.6	0.91
Total Current Assets	150.42	168.95	208	249.99	41.07	11.31
Property, Plant & Equipment	7.43	10.5	12.89	10.45	7.46	0.38
Long-Term Investments	14.39	5.92	10.94	0	0	0
Goodwill and Intangibles	2.36	2.49	2.61	2.73	2.86	2.98
Other Long-Term Assets	3.17	5.81	0.73	0.54	2.14	0.35
Total Long-Term Assets	27.36	24.72	27.17	13.72	12.46	3.71
Total Assets	177.78	193.68	235.17	263.71	53.53	15.01
Accounts Payable	1.5	1.76	1.58	1.47	2.68	1.29
Deferred Revenue	0.1	0.12	0.16	0.07	0.17	0.14
Current Debt	5.23	3.32	2.29	2.24	0.45	0
Other Current Liabilities	16.33	13.3	13.51	8.75	10.86	6.64
Total Current Liabilities	23.16	18.49	17.55	12.53	14.16	8.07
Long-Term Debt	36.2	21.08	24.17	24.99	21.37	33.61
Other Long-Term Liabilities	0.11	0.09	0.22	0.06	0.04	0.13
Total Long-Term Liabilities	36.31	21.18	24.38	25.05	21.41	33.73
Total Liabilities	59.47	39.67	41.93	37.57	35.57	41.8
Total Debt	41.42	24.4	26.46	27.22	21.81	33.61
Debt Growth	69.76%	-7.78%	-2.81%	24.80%	-35.09%	-
Retained Earnings	-411.16	-350.32	-291.4	-242.73	-210.5	-189.8
Comprehensive Income	2.64	1.58	1.71	1.69	1.37	1.33
Shareholders' Equity	118.32	154.01	193.24	226.13	-187.38	-167.33
Net Cash / Debt	75.92	116.97	153.81	204.57	6.53	-29.48
Net Cash / Debt Growth	-35.10%	-23.95%	-24.81%	3031.30%	-	-
Net Cash Per Share	2.00	3.15	4.26	20.09	3.68	-17.60
Working Capital	127.27	150.46	190.45	237.46	26.91	3.24
Book Value Per Share	3.12	4.15	5.35	22.20	-105.50	-99.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).